Pharmacelera, the leading provider of computational tools for hit discovery, and Welab, the leading drug discovery and development platform is Spain, have announced a partnership to jointly provide an efficient solution from hit finding up to pre-clinical development of new chemical entities.
The collaboration will provide integrated resources, expertise, and capabilities for speeding up new discoveries, and therapeutic opportunities to research groups from academy, biotech, or pharmaceutical industry.